Logos Global Management as of Sept. 30, 2023
Portfolio Holdings for Logos Global Management
Logos Global Management holds 53 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunovant (IMVT) | 8.2 | $61M | 1.6M | 38.39 | |
| Ideaya Biosciences (IDYA) | 8.1 | $61M | 2.3M | 26.98 | |
| Apellis Pharmaceuticals (APLS) | 7.1 | $53M | 1.4M | 38.04 | |
| Olema Pharmaceuticals (OLMA) | 6.2 | $46M | 3.7M | 12.35 | |
| Rocket Pharmaceuticals (RCKT) | 5.4 | $41M | 2.0M | 20.49 | |
| Cytokinetics Com New (CYTK) | 4.9 | $37M | 1.3M | 29.46 | |
| Akero Therapeutics (AKRO) | 4.0 | $30M | 600k | 50.58 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.4 | $25M | 500k | 50.42 | |
| Sarepta Therapeutics (SRPT) | 3.2 | $24M | 200k | 121.22 | |
| Bridgebio Pharma (BBIO) | 3.2 | $24M | 900k | 26.37 | |
| Immunocore Hldgs Ads (IMCR) | 3.1 | $23M | 450k | 51.90 | |
| Icosavax | 2.9 | $21M | 2.8M | 7.75 | |
| Dyne Therapeutics (DYN) | 2.6 | $20M | 2.2M | 8.96 | |
| Karuna Therapeutics Ord | 2.6 | $19M | 115k | 169.09 | |
| Neurocrine Biosciences (NBIX) | 2.3 | $17M | 150k | 112.50 | |
| Miragen Therapeutics (VRDN) | 2.1 | $16M | 1.1M | 15.34 | |
| Xenon Pharmaceuticals (XENE) | 2.1 | $15M | 450k | 34.16 | |
| Cerevel Therapeutics Hldng I (CERE) | 2.0 | $15M | 700k | 21.83 | |
| Roivant Sciences SHS (ROIV) | 1.9 | $14M | 1.2M | 11.68 | |
| Mirati Therapeutics | 1.7 | $13M | 300k | 43.56 | |
| Annexon (ANNX) | 1.7 | $13M | 5.3M | 2.36 | |
| Immatics SHS (IMTX) | 1.6 | $12M | 1.1M | 11.58 | |
| Design Therapeutics (DSGN) | 1.6 | $12M | 5.0M | 2.36 | |
| Allakos (ALLK) | 1.4 | $11M | 4.7M | 2.27 | |
| Repare Therapeutics Ord (RPTX) | 1.3 | $9.7M | 800k | 12.08 | |
| Rhythm Pharmaceuticals (RYTM) | 1.2 | $9.2M | 400k | 22.93 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $8.7M | 900k | 9.63 | |
| Ventyx Biosciences (VTYX) | 1.0 | $7.8M | 225k | 34.73 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.0 | $7.4M | 250k | 29.74 | |
| Gracell Biotechnologies Sponsored Ads | 1.0 | $7.3M | 2.5M | 2.88 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.9 | $7.0M | 950k | 7.40 | |
| Revolution Medicines (RVMD) | 0.9 | $6.9M | 250k | 27.68 | |
| Morphosys Sponsored Ads (MOR) | 0.9 | $6.4M | 950k | 6.72 | |
| Geron Corporation (GERN) | 0.8 | $5.8M | 2.8M | 2.12 | |
| Merus N V (MRUS) | 0.8 | $5.8M | 245k | 23.58 | |
| Alx Oncology Hldgs (ALXO) | 0.6 | $4.8M | 1.0M | 4.80 | |
| 89bio (ETNB) | 0.6 | $4.8M | 310k | 15.44 | |
| Iovance Biotherapeutics Call Option (IOVA) | 0.6 | $4.6M | 1.0M | 4.55 | |
| Delcath Sys Com New (DCTH) | 0.6 | $4.2M | 1.0M | 4.05 | |
| Enliven Therapeutics (ELVN) | 0.6 | $4.2M | 307k | 13.66 | |
| Astria Therapeutics (ATXS) | 0.5 | $4.1M | 545k | 7.46 | |
| Soleno Therapeutics (SLNO) | 0.5 | $3.7M | 125k | 29.51 | |
| Verve Therapeutics (VERV) | 0.4 | $2.9M | 215k | 13.26 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.4 | $2.8M | 424k | 6.60 | |
| Aeglea Biotherapeutics Com New (SYRE) | 0.3 | $2.6M | 210k | 12.25 | |
| Ambrx Biopharma Sponsored Ads | 0.2 | $1.3M | 115k | 11.50 | |
| Vigil Neuroscience (VIGL) | 0.1 | $1.0M | 188k | 5.39 | |
| Io Biotech (IOBT) | 0.1 | $696k | 494k | 1.41 | |
| Immunic (IMUX) | 0.1 | $619k | 421k | 1.47 | |
| Leap Therapeutics Com New (LPTX) | 0.1 | $489k | 354k | 1.38 | |
| Tyra Biosciences (TYRA) | 0.1 | $439k | 32k | 13.77 | |
| Lianbio Sponsored Ads (LIANY) | 0.1 | $417k | 280k | 1.49 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $6.7k | 67k | 0.10 |
